SCHEMBL3074129

SCHEMBL3074129

Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)C(=O)O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKAA1 Q13131 8/20 0.73
PRKAA2 P54646 7/20 0.73
PDGFRB P09619 11/20 0.72
KDR P35968 10/20 0.72
CSF1R P07333 4/20 0.72
ABCB11 O95342 2/20 0.72
TLK2 Q86UE8 5/20 0.72
FGFR1 P11362 6/20 0.71
HDAC3 O15379 3/20 0.70
HDAC4 P56524 3/20 0.70
HDAC1 Q13547 3/20 0.70
HDAC7 Q8WUI4 3/20 0.70
HDAC2 Q92769 3/20 0.70
HDAC10 Q969S8 3/20 0.70
HDAC11 Q96DB2 3/20 0.70
HDAC8 Q9BY41 3/20 0.70
HDAC6 Q9UBN7 3/20 0.70
HDAC9 Q9UKV0 3/20 0.70
HDAC5 Q9UQL6 3/20 0.70
ALK Q9UM73 3/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3057209 1.00 PRKAA1 (0.73) PRKAA1PRKAA2PDGFRBKDRCSF1R
SCHEMBL13092040 0.93 PRKAA1 (0.73) PRKAA1PRKAA2PDGFRBKDRCSF1R
SCHEMBL13092042 0.93 PRKAA1 (0.73) PRKAA1PRKAA2PDGFRBKDRCSF1R
SCHEMBL13092039 0.93 PRKAA1 (0.73) PRKAA1PRKAA2PDGFRBKDRCSF1R
SCHEMBL3051755 0.91 PRKAA1 (0.71) PRKAA1PRKAA2PDGFRBKDRCSF1R
SCHEMBL13091976 0.91 PRKAA1 (0.71) PRKAA1PRKAA2PDGFRBKDRCSF1R
SCHEMBL13101763 0.91 PRKAA1 (0.76) PRKAA1PRKAA2PDGFRBKDRCSF1R
SCHEMBL3070262 0.91 PRKAA1 (0.76) PRKAA1PRKAA2PDGFRBKDRCSF1R
SCHEMBL13091973 0.91 PDGFRB (0.73) PRKAA1PRKAA2PDGFRBKDRCSF1R
SCHEMBL13091963 0.91 PDGFRB (0.73) PRKAA1PRKAA2PDGFRBKDRCSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100267719-A1 Enhanced Indolinone Based Protein Kinase Inhibitors THE SCRIPPS RESEARCH INSTITUTE (US) 2010-10-21 US disclosed
US-20100267719-A1 Enhanced Indolinone Based Protein Kinase Inhibitors THE SCRIPPS RESEARCH INSTITUTE (US) 2010-10-21 US disclosed
US-20100267719-A1 Enhanced Indolinone Based Protein Kinase Inhibitors THE SCRIPPS RESEARCH INSTITUTE (US) 2010-10-21 US disclosed
EP-1893194-A4 ENHANCED INDOLINONE BASED PROTEIN KINASE INHIBITORS SCRIPPS RESEARCH INST (US) 2009-07-01 EP disclosed
EP-1893194-A1 ENHANCED INDOLINONE BASED PROTEIN KINASE INHIBITORS The Scripps Research Institute (US) 2008-03-05 EP disclosed
US-20060287381-A1 Enhanced indolinone based protein kinase inhibitors THE SCRIPPS RESEARCH INSTITUTE (US) 2006-12-21 US disclosed
WO-2006127961-A1 ENHANCED INDOLINONE BASED PROTEIN KINASE INHIBITORS THE SCRIPPS RESEARCH INSTITUTE (US) 2006-11-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060287381-A1 Enhanced indolinone based protein kinase inhibitors PHKG1, PHKG2, PRKCH PRKAA1 5/4885PRKAA2 8/4885PDGFRB 388/4885
US-20100267719-A1 Enhanced Indolinone Based Protein Kinase Inhibitors PHKG1, PHKG2, PRKCH PRKAA1 6/4885PRKAA2 9/4885PDGFRB 394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.